Mayo Medical Laboratories Now Offering Galectin-3 Diagnostic Testing

Heart failure mediated by elevated levels of a protein called galectin-3 affects between 30 percent and 50 percent of chronic heart failure patients and is associated with higher rates of mortality and rehospitalization. Mayo Medical Laboratories now offers galectin-3 testing to aid in the prognosis of patients diagnosed with chronic heart failure.

To learn more about galectin-3 and how to order tests, please visit:

mayocliniclabs

Mayo Medical Laboratories

This post was authored by the Marketing Team at Mayo Medical Laboratories.